Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02330276 · ClinicalTrials.gov registry record · Phase 1
Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin
A Phase 1 study, sponsored by Veterans Medical Research Foundation.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT02330276: Completed Phase 1 study, sponsored by Veterans Medical Research Foundation.
NCT02330276 is a Phase 1 study that has completed, run by Veterans Medical Research Foundation. The registered enrollment target is 12 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02330276, a Phase 1 study, has completed, sponsored by Veterans Medical Research Foundation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
Early Phase Pre-Clinical and Initial Clinical Research on (+)- Epicatechin.
Primary Outcome
This will be initial PK study on synthetic (+)-epicatechin in humans. Circulating and urinary concentrations of intact epicatechin and epicatechin metabolites, including specific enantiomers
Interventions
- DRUG (+)-Epicatechin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-08 |
| Phase | Phase 1 |
What the finished NCT02330276 record still lists
NCT02330276 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 1 intervention - of which (+)-Epicatechin is the first listed.
NCT02330276 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02330276 about?
NCT02330276 is a clinical study titled "Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin". Early Phase Pre-Clinical and Initial Clinical Research on (+)- Epicatechin.
What is the current status of trial NCT02330276?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2014-09. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02330276?
The interventions under investigation include: (+)-Epicatechin (DRUG).
Who is sponsoring clinical trial NCT02330276?
This trial is sponsored by Veterans Medical Research Foundation, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02330276's enrollment target sits among peer trials
12 1852nd of 2000 higher than 90 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia